1 st quarter results 2006 zentiva nv may 2 first report i highlights total sales up 11 9 to czk 3 176 4 million from 839 in q1 2005 driven by a 23 increase pharmaceutical which now represent over 94 of comprising 21 prescription and 35 chc consumer healthcare 41 8 growth poland 119 7 russia 457 romania 16 6 decline czech 104 gross profit margin increased 65 versus 63 for the three months net period attributable equity holders declined 13 510 5 due higher marketing investments interest costs this represents diluted eps 37 free cash flow before acquisitions was 240 representing tax finance conversion 31 holds 74 sa
